BlackRock’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.61B Buy
13,683,865
+2,234,096
+20% +$593M 0.1% 159
2026
Q1
$1.25B Sell
11,449,769
-1,519,089
-12% -$216M 0.02% 585
2025
Q4
$2.16B Buy
12,968,858
+1,739,429
+15% +$291M 0.04% 391
2025
Q3
$2.2B Buy
11,229,429
+4,105,012
+58% +$675M 0.04% 380
2025
Q2
$644M Buy
7,124,417
+2,471,597
+53% +$195M 0.01% 879
2025
Q1
$278M Sell
4,652,820
-2,002,000
-30% -$185M 0.01% 1398
2024
Q4
$881M Buy
6,654,820
+4,422,959
+198% +$415M 0.02% 721
2024
Q3
$117M Buy
2,231,861
+742,252
+50% +$34.8M ﹤0.01% 1994
2024
Q2
$90.1M Buy
1,489,609
+639,609
+75% +$44.4M ﹤0.01% 2087
2024
Q1
$63.1M Buy
+850,000
New +$63M ﹤0.01% 2312

Other funds holding ALAB

BlackRock's ALAB Position: Q2 2026 in Review

BlackRock increased its Astera Labs (ALAB) stake by 20% in Q2 2026, buying an estimated $593M and bringing the position to 13,683,865 shares worth $6.61B. The position accounts for 0.1% of the portfolio, ranked #159.

BlackRock first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • BlackRock held 13,683,865 shares of Astera Labs worth $6.61B as of Q2 2026.
  • BlackRock bought 2,234,096 Astera Labs shares in Q2 2026, an estimated $593M.
  • Astera Labs made up 0.1% of BlackRock's portfolio in Q2 2026, its #159 holding.
  • BlackRock first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.